Business Daily from THE HINDU group of publications
Tuesday, February 01, 2011
ePaper | Mobile/PDA Version | Audio | Blogs

News
Features
Stocks
Foreign Exchange
Shipping
Archives
Google

Subscription

Group Sites

Resources
Pharmaceuticals
  • Premature reaction to Suven’s US patent (December 28, 2007)
  • Suven Life bags US patent for compounds for neuro drug (December 28, 2007)
  • Neuland hiking borrowing limit (December 25, 2007)
  • Shot in the arm (December 23, 2007)
  • HCL strengthens ties with Merck (December 20, 2007)
  • NPIL ties up with Japanese co (December 20, 2007)
  • Suven Life to raise $30 m (December 19, 2007)
  • Cognizant inks deal with Merck (December 19, 2007)
  • Pfizer short of clinical research staff (December 19, 2007)
  • Flamingo Pharma enters TN (December 18, 2007)
  • Today's Pick: Glaxo Pharma (Rs 1063.40) (December 18, 2007)
  • Day trading guide (December 18, 2007)
  • Today's Pick:Cipla (Rs 209.15) (December 17, 2007)
  • Bilcare Centre of Excellence opened (December 17, 2007)
  • ‘Nanomedicine is at the frontline of new drug delivery’ (December 15, 2007)
  • Positive Solutions develops pharma ERP system (December 15, 2007)
  • Global tenders floated for bio safety facility (December 13, 2007)
  • Suven to take part in pharma meet (December 12, 2007)
  • Nicholas Piramal gets US patent for cancer compounds (December 11, 2007)
  • Cipla taking relook at Goa SEZ project (December 09, 2007)
  • Pact: Sun Pharma to save on legal costs (December 07, 2007)
  • Jubilant arm teams up with Forest Lab (December 07, 2007)
  • Natco launches breast cancer drug (December 07, 2007)
  • Ranbaxy gets marketing nod for paediatric anti-retrovirals (December 07, 2007)
  • Perot Systems chosen by US body to certify coding specialists (December 07, 2007)
  • Matrix Lab gets US FDA nod for AIDS drug (December 06, 2007)
  • Today's Pick: JB Chemicals (Rs 71.45) (December 06, 2007)
  • Dutch co DSM ties up with Arch Pharma (December 05, 2007)
  • Vivimed Labs pref allotment (December 05, 2007)
  • Nicholas oncology drug phase 2 trials in Jan (December 04, 2007)
  • Venkat Jasti is Pharmexcil chief (December 01, 2007)
  • Tatas open pharma R&D centre in Bangalore (November 30, 2007)
  • Focus on basics pays for Orchid Chem (November 28, 2007)
  • Suven gets 2 European patents for neuro treatment (November 28, 2007)
  • Argenta, Dr Reddy’s develop respiratory drug (November 27, 2007)
  • GVK Bio raises Rs 100 cr from Sequoia Capital (November 27, 2007)
  • In big league (November 25, 2007)
  • E&Y award for Cyrus Poonawala (November 23, 2007)
  • US nod for Aurobindo products (November 23, 2007)
  • Lyka Labs plans pref allotment (November 23, 2007)
  • New pharma regulations open up biz to Spectrum (November 22, 2007)
  • Ranbaxy’s Flomax for Canada (November 22, 2007)
  • Today's Pick: Novartis India (Rs 348.10) (November 21, 2007)
  • Strides Arcolab forays into anti-cancer product segment (November 21, 2007)
  • UAS Pharma unveils dermatological products (November 20, 2007)
  • Venus to take Potentox injectable overseas (November 20, 2007)
  • Marck Biosciences enters AP (November 20, 2007)
  • Merck deal: Positive for Nicholas Piramal (November 20, 2007)
  • Natco Pharma allots 4.66 lakh shares (November 17, 2007)
  • Ranbaxy recalls epilepsy drug in the US (November 17, 2007)
  • Dr Reddy’s new diabetic drug balaglitazone to hit market in 2011 (November 16, 2007)
  • HC nod for Indoco demerger (November 16, 2007)
  • Cipla gets another Govt notice on overcharging (November 15, 2007)
  • Resolving patent row is bonus for Ranbaxy (November 13, 2007)
  • Avon Organics plans pref issue (November 13, 2007)
  • Disputes pay (November 11, 2007)
  • Nicholas Piramal: Buy (November 11, 2007)
  • Flomax: Ranbaxy reaches agreement (November 10, 2007)
  • Fire at Aurobindo Pharma unit (November 08, 2007)
  • Glaxo Pharma’s new move to be lucrative (November 08, 2007)
  • GSK set to launch cancer drug Tykerb in India (November 07, 2007)
  • Advinus reaches first goal for Merck (November 06, 2007)
  • Suven Life showcases new chem entities (November 06, 2007)
  • Jubilant Organosys: Buy (November 04, 2007)
  • Ozone Group unveils protein sequencer (November 03, 2007)
  • VLife completes pre-clinical trials for diabetic wound drug (November 02, 2007)
  • Indiresan on Matrix board (November 02, 2007)
  • Ranbaxy gets tentative USFDA nod for generic Diovan (November 02, 2007)
  • Suven Life gets patents (November 02, 2007)
  • Pochiraju to launch speciality unit (November 02, 2007)
  • Aurobindo nod for ESOP options (November 02, 2007)
  • Cipla gets Govt notice for over-charging (November 02, 2007)
  • Chill pill (November 01, 2007)
  • Biotech, pharma set for big leap (November 01, 2007)
  • Dabur Pharma may sell Irinotecan in US (November 01, 2007)
  • Sparsha to invest $20 m in pain-relief drug unit (October 29, 2007)
  • Lupin: Buy (October 28, 2007)
  • Suven, US varsity in pact (October 27, 2007)
  • Glenmark in marketing tie-up with MyerZall Labs (October 27, 2007)
  • Wockhardt’s buy to strengthen US market (October 25, 2007)
  • USFDA nod for Sun Pharma drug (October 24, 2007)
  • Patent for 3 Suven products (October 24, 2007)
  • HC order on Novartis appeal hearing likely today (October 23, 2007)
  • Ranbaxy gets nod for Lisinopril (October 23, 2007)
  • Medicine Shoppe eyes Hyderabad, Pune markets (October 22, 2007)
  • Reliance enters wellness format; opens outlet in Hyderabad (October 20, 2007)
  • Biocon gets nod to market breast cancer drug (October 19, 2007)
  • Indoco plans tie-up with US co (October 19, 2007)
  • USV in marketing tie-up with Germany’s Sebapharma (October 19, 2007)
  • Ocimum Bio buys US co Gene Logic’s genomic biz (October 18, 2007)
  • IBPL signs R&D pact with Viropro of Canada (October 17, 2007)
  • Dabur Pharma launches cancer drug in UK (October 16, 2007)
  • Wockhardt in pact with UK co for acne product (October 16, 2007)
  • Nice moves (October 14, 2007)
  • Philips to showcase pre-clinical tool (October 13, 2007)
  • Lupin gets €20 m in patent sale deal (October 13, 2007)
  • Panacea, Punjab varsity in pact (October 12, 2007)
  • Glenmark launch: Only a short-term benefit (October 12, 2007)
  • UK co ClinTec entering drug development (October 12, 2007)
  • Kotak to invest $10 m in Intas Biopharma (October 12, 2007)
  • Sun Pharma gets US nod for Trileptal (October 11, 2007)
  • Lupin takes majority stake in Japanese generic co (October 11, 2007)
  • Shasun Chem may split research, manufacturing operations (October 11, 2007)
  • Buyout: No short-term benefits for Lupin (October 11, 2007)
  • Today's Pick: Cadila Healthcare (Rs 299.5) (October 09, 2007)
  • DLF will replace Dr. Reddy’s in Sensex (October 09, 2007)
  • Govt suggests revised approach to Glivec case (October 09, 2007)
  • Biopharma strategy (October 07, 2007)
  • GVK Bio looking at deal with private equity players (October 07, 2007)
  • Wyeth Pharma to beef up India presence (October 07, 2007)
  • Aurobindo gets UK nod for Unit-X1 (October 07, 2007)
  • Open offer for Zenotech (October 06, 2007)
  • Panacea Biotec in pact to sell vaccines in Philippines (October 06, 2007)
  • Avesthagen arm acquires Swiss co Siegfried Biologics (October 06, 2007)
  • NPIL merging healthcare arm (October 06, 2007)
  • Ranbaxy gets nod for Biaxin generic (October 05, 2007)
  • Ranbaxy to ride biopharma wave (October 04, 2007)
  • TCG Lifesciences plans capital market foray (October 04, 2007)
  • Eli Lilly’s new diabetic drug (October 04, 2007)
  • Cadila looking at fresh jt ventures in Europe, Gulf (October 02, 2007)
  • ICICI Bank loan for clinical research body (October 02, 2007)
  • Serum Institute to tap US, European markets (September 29, 2007)
  • Intas Pharma wins excellence award (September 29, 2007)
  • Lupin acquires Rubamin (September 28, 2007)
  • Re rise may hit Shasun Chem bottomline (September 28, 2007)
  • Suven Life to raise $50 m (September 28, 2007)
  • Indiastar (Mauritius) picks up 18.5% stake in IOL Chemicals (September 28, 2007)
  • Today's Pick: Alembic (Rs 85) (September 26, 2007)
  • Zydus Cadila gets USFDA nod (September 26, 2007)
  • Ranbaxy partners Sirtex to sell liver cancer drug (September 25, 2007)
  • Waters India turns 20, sees strong growth (September 22, 2007)
  • Biocon to widen oral insulin trials (September 22, 2007)
  • FIPB wants probe into Danone pie in Avesthagen (September 22, 2007)
  • Morepen to offload 15% stake to Avenue Capital (September 21, 2007)
  • Jubilant extends association with Syngenta (September 19, 2007)
  • Today’s Pick: Lupin (Rs 592.10) (September 18, 2007)
  • Ajanta Pharma in deal with Canadian co (September 14, 2007)
  • Dr Reddy’s gets USFDA nod for Ranitidine (September 14, 2007)
  • Ipca buys Australian co (September 14, 2007)
  • Aurobindo gets UK certificate (September 14, 2007)
  • Lipitor case: Ranbaxy to contest Canadian court ruling (September 14, 2007)
  • Favourable ruling lifts Lupin (September 14, 2007)
  • Natco launches cancer drug (September 12, 2007)
  • Sun to sell generic protonix in US (September 12, 2007)
  • 3 Ranbaxy products added to WHO list (September 11, 2007)
  • Dept of Biotechnology undertakes study to scan microbes for antibiotics (September 11, 2007)
  • UK certificate for Aurobindo unit (September 08, 2007)
  • Dow to make India its R&D hub (September 08, 2007)
  • Aurobindo unit gets FDA nod (September 07, 2007)
  • Raghuveer Kini is Pharmexcil ED (September 07, 2007)
  • Sun Pharma deal may not upset Taro’s outsourcing (September 07, 2007)
  • Today’s Pick: Sun Pharma (September 07, 2007)
  • Jubilant Organosys gets award (September 06, 2007)
  • Dr Reddy’s anti-fungal foray (September 06, 2007)
  • TCS inks deal with Roche for capacity building initiative (September 05, 2007)
  • The Novartis saga — Prescription for patent strategy in India (September 05, 2007)
  • Bharat Biotech launches 2 vaccines (September 04, 2007)
  • Divis Labs interim dividend (September 04, 2007)
  • Alkem Labs sees potential in health foods segment (August 31, 2007)
  • Zydus Cadila files IND application (August 31, 2007)
  • Abbott to consider buyback (August 30, 2007)
  • Elder Pharma acquires Bulgarian co for Rs 28 cr (August 29, 2007)
  • Ipca, CDRI pact for malaria drug (August 29, 2007)
  • Food, drugs and ethics (August 28, 2007)
  • Nicholas Piramal to take up research unit revamp at board meet (August 28, 2007)
  • Elder Healthcare plans introducing more products (August 28, 2007)
  • Apotex has big plans for Bangalore R&D unit (August 26, 2007)
  • Spices Board setting up centre for value-addition (August 25, 2007)
  • Glochem tapping Europe, US markets (August 25, 2007)
  • Cipla plans Rs 950-cr capacity expansion (August 25, 2007)
  • Ess Dee to launch slew of new products (August 24, 2007)
  • Arch PharmaLabs acquires Watsol Organics (August 23, 2007)
  • US nod for Dabur’s cancer injection (August 23, 2007)
  • Ranbaxy launches urology drug (August 23, 2007)
  • USFDA nod for Ranbaxy’s pain relieving drug (August 21, 2007)
  • Aurobindo to use MetricStream tool (August 21, 2007)
  • Cipla launches emergency contraception tablet (August 21, 2007)
  • MSN Laboratories forays into formulations (August 18, 2007)
  • Aarti Drugs MD resigns (August 18, 2007)
  • Ajanta inks tech transfer deal with Taiwanese co (August 18, 2007)
  • MSN Laboratories forays into formulations (August 18, 2007)
  • Ajanta inks tech transfer deal with Taiwanese co (August 18, 2007)
  • Aarti Drugs MD resigns (August 18, 2007)
  • Glochem to sell drugs in US (August 17, 2007)
  • Jubilant Organosys expands pyridines capacity (August 16, 2007)
  • Flamingo Pharma enters West India (August 15, 2007)
  • Lupin’s President-Finance (August 14, 2007)
  • USV identifies Hepatitis C vaccine candidate (August 14, 2007)
  • Effects on R&D (August 14, 2007)
  • Matrix ties up with Canadian co for contract research (August 12, 2007)
  • MSD India launches Invanz (August 11, 2007)
  • Chiron launches Hepatitis A vaccine (August 11, 2007)
  • AIDS drug not sold in Africa, says Cipla (August 10, 2007)
  • Biocon to market Abraxis drug (August 10, 2007)
  • HC stays IPAB proceedings on Novartis plea (August 10, 2007)
  • Torrent launches laxative (August 10, 2007)
  • Strides gets nod for nausea drug (August 09, 2007)
  • Allergan opens R&D centre in Bangalore (August 09, 2007)
  • Research-oriented cos may stay away: Novartis (August 07, 2007)
  • Nectar Life betting on volume, margins (August 07, 2007)
  • Glivec-impact: ‘Thumb’s up for public health’ (August 07, 2007)
  • Strides completes Diaspa buy (August 07, 2007)
  • Alpa Labs lists below IPO price (August 07, 2007)
  • Glivec case: Madras HC judgment likely today (August 06, 2007)
  • Biocon in Dubai (August 05, 2007)
  • Diabetes drug: Dr Reddy’s, Danish co start phase III trials (August 02, 2007)
  • Novartis moves HC for new IP Board member (August 02, 2007)
  • Ess Dee consolidated net at Rs 16 cr (August 01, 2007)
  • Avandia to be available in India: GSK (August 01, 2007)
  • Biocon, Neopharma launch Dubai venture (July 31, 2007)
  • Alembic completes 100 years (July 31, 2007)
  • Ranbaxy launches generic drug in US (July 31, 2007)
  • Wockhardt to integrate Europe, India operations in 6 months (July 30, 2007)
  • Finding the cure (July 29, 2007)
  • Themis, Aventis in tech-transfer deal (July 28, 2007)
  • GSK Pharma exits fine chemicals biz (July 27, 2007)
  • Zydus Cadila eyes acquisitions in Mexico, S. Africa, CIS nations (July 27, 2007)
  • Ipca-Ranbaxy drug gets US nod (July 26, 2007)
  • Pharmacological society meet (July 26, 2007)
  • Orchid gets US FDA nod for Cefdinir (July 25, 2007)
  • Dr Reddy’s gearing up to be in global top-10 league (July 25, 2007)
  • Taro shareholders given time on Sun Pharma’s proposal (July 24, 2007)
  • Dr Reddy’s betting big on ‘myDREEM’ project (July 22, 2007)
  • Appellate board dismisses Novartis objection (July 21, 2007)
  • Aurobindo gets FDA nod (July 21, 2007)
  • Glenmark buys two antibodies from Canada’s Chromos (July 20, 2007)
  • Sun Pharma’s de-merged arm gets listed at Rs 87.15 on BSE (July 19, 2007)
  • Relief’s flavour (July 19, 2007)
  • Orchid Chem launching 3 products in US this year (July 18, 2007)
  • World Bank debars two Indian firms (July 18, 2007)
  • Ranbaxy shuts down ‘unviable’ Pune formulations plant (July 14, 2007)
  • Suven seeks nod for drug trials (July 14, 2007)
  • MSN group acquires Armour Pharma unit (July 13, 2007)
  • Natco acquires pharmacy in US (July 13, 2007)
  • Novartis case: Stage set for order on IPAB appointment (July 12, 2007)
  • Dr. Reddy’s ESOP allotment (July 12, 2007)
  • Sub-division of Divi’s shares cleared (July 11, 2007)
  • Shasun in pact with Danish co (July 11, 2007)
  • Dr Reddy’s launches new diabetes drugs (July 11, 2007)
  • ‘Expats find securing work permit complicated’ (July 10, 2007)
  • Wockhardt looking for insulin launch in US, Europe (July 10, 2007)
  • Wockhardt gets US nod for epileptic drug (July 10, 2007)
  • Hikal inks deal with US co for veterinary drug (July 10, 2007)
  • Dishman Pharma to buy Solvay unit (July 10, 2007)
  • Divi’s Lab on a roll (July 10, 2007)
  • Alpa Labs IPO at Rs 62-68 (July 10, 2007)
  • Shasun facility gets US FDA nod (July 07, 2007)
  • Suven to showcase preclinical data (July 06, 2007)
  • CD Pharma keen on licensing pact with big cos for probiotics (July 06, 2007)
  • Granules ties up with US co (July 06, 2007)
  • USV gets USFDA nod for Daman facility (July 05, 2007)
  • Aurobindo drug gets FDA nod (July 04, 2007)
  • Sun Pharma to raise Rs 3,500 cr (July 04, 2007)
  • Zenotech bets big on biological entities (July 04, 2007)
  • Venus Remedies launching drug to detect cancer thru x-ray (July 04, 2007)
  • Govt hearing on Glivec next week (July 03, 2007)
  • Pharmalink buys Lilly’s brand (July 01, 2007)
  • Natco drug gets USFDA nod (June 27, 2007)
  • Shantha Bio, PATH in pact for rotavirus vaccine (June 27, 2007)
  • International pharma meet from today (June 27, 2007)
  • Aurobindo BP drug gets USFDA nod (June 27, 2007)
  • Clarification (June 26, 2007)
  • Ranbaxy launches Pravastatin in US (June 26, 2007)
  • Zydus Cadila buys Brazil's Nikkho for $26 m (June 26, 2007)
  • Tripex setting up pharma SEZ (June 24, 2007)
  • Natco Pharma launches oral contraceptive (June 23, 2007)
  • Wyeth launches Tygacil (June 23, 2007)
  • Dabur Pharma plans generic versions of Sanofi's Eloxatin (June 23, 2007)
  • Ranbaxy gets tentative USFDA nod for Flomax (June 23, 2007)
  • Aptuit to make India its manufacturing base (June 23, 2007)
  • PerkinElmer buys 100% in Indian arm (June 22, 2007)
  • HealthCare Global to launch 2 cancer drugs (June 22, 2007)
  • `Efficacy' factor will be key to Glivec patent case (June 22, 2007)
  • Nod for APL drug (June 21, 2007)
  • Ranbaxy gets tentative approval for generic Norvasc (June 21, 2007)
  • Lupin resolves case on Cefdinir (June 20, 2007)
  • United Biotech in pact to sell Swedish amino acid tablets (June 20, 2007)
  • Indoco plans to merge pharma operations (June 20, 2007)
  • Aurobindo's ARV drug gets nod (June 20, 2007)
  • Glivec: Novartis objects to bench composition (June 19, 2007)
  • TCG partners with Forest for drug candidates (June 19, 2007)
  • Panacea Biotec scouts for overseas acquisition (June 17, 2007)
  • Matrix allots ESOP shares (June 16, 2007)
  • Dr Reddy's opens office in Nigeria (June 16, 2007)
  • Optra Systems launches Centre of Excellence (June 16, 2007)
  • Aurobindo gets USFDA nod (June 16, 2007)
  • FDA nod for Trandolapril (June 16, 2007)
  • Aarti Ind, Aarti Drugs merger on cards (June 15, 2007)
  • IFC offers $15-m funding for Granules (June 15, 2007)
  • Serum Institute set for flu vaccine launch in July (June 15, 2007)
  • Fortis plans Rs 800-cr retail spend (June 14, 2007)
  • Aurobindo Pharma setting up R&D arm (June 14, 2007)
  • Zydus Cadila gets USFDA nod for new products (June 13, 2007)
  • Ansal, Fortis Healthcare may ink deal for Fortis Medicity (June 13, 2007)
  • Second-rung pharma stocks outdo index since May (June 13, 2007)
  • RPG Life Sciences spins off pharma, investment arms (June 13, 2007)
  • Suven Life gets USFDA nod (June 12, 2007)
  • Nicholas Piramal eyeing clinical research in biotech segment (June 11, 2007)
  • Bio-Rad looks at 20% growth in India sales (June 09, 2007)
  • Dr Reddy's launches dermatology drug (June 09, 2007)
  • AstraZeneca appointments (June 08, 2007)
  • US nod for two more Strides drugs (June 07, 2007)
  • Alkem Lab unveils wound-care product (June 07, 2007)
  • Tentative nod for Zydus drug (June 07, 2007)
  • Novartis case at Madras High Court awaits judgment (June 07, 2007)
  • APL's Ciprofloxacin gets nod (June 07, 2007)
  • Aurobindo drug gets USFDA nod (June 06, 2007)
  • Suven Life to sharpen focus on drug discovery activity (June 05, 2007)
  • Flamingo launches products in TN (June 04, 2007)
  • Jubilant completes acquisition of Hollister-Stier (June 02, 2007)
  • Glenmark: Betting on product (June 02, 2007)
  • Intas Biopharma signs pact with Virionics Corp (June 01, 2007)
  • Wockhardt set for US launch of Lamisil clone (June 01, 2007)
  • Generics rolls out Finasteride in UK (June 01, 2007)
  • Shasun chalks out Rs 200-cr capex outlay (June 01, 2007)
  • Kopran seeks shareholders nod for pref allotment (May 31, 2007)
  • Aurobindo drug gets US FDA nod (May 30, 2007)
  • Elder Pharma ties up with Cymbiotics (May 30, 2007)
  • Eli Lilly working on diabetes injectible drug (May 30, 2007)
  • Strides enters fermentation biz; buys Italian company's unit (May 30, 2007)
  • Eli Lilly launches diabetes awareness campaign (May 29, 2007)
  • Glenmark starting phase II trials on pain drug molecule (May 29, 2007)
  • Ranbaxy gets rights for 13 dermatology products in US (May 29, 2007)
  • Safety concerns on GSK's Avandia may have `class effect' (May 29, 2007)
  • Sun Pharma-Taro: Another testimony to `can do' attitude of Indian cos (May 28, 2007)
  • United Biotech ties up with Italian co (May 26, 2007)
  • Drug delivery (May 24, 2007)
  • Exports not affecting domestic formulations biz: Alembic (May 23, 2007)
  • Marck Bio targeting South for parenterals (May 23, 2007)
  • Ranbaxy gets nod to sell cholesterol drug in Canada (May 22, 2007)
  • Ranbaxy gets tentative USFDA nod for Allegra (May 20, 2007)
  • Matrix Lab's N. Prasad tops list (May 19, 2007)
  • Wockhardt to start work at Aurangabad SEZ soon (May 19, 2007)
  • Laxai setting up data centre in Hyderabad (May 19, 2007)
  • Dr Reddy's posts $75 m net income in Q4 (May 19, 2007)
  • IDPL revival referred to panel (May 19, 2007)
  • New Chairman for Sami group (May 18, 2007)
  • Natco launches generic version of multiple sclerosis drug (May 17, 2007)
  • Natco expanding retail presence in US (May 16, 2007)
  • Lupin cholesterol drug gets US nod (May 16, 2007)
  • Jupiter Bio makes pref offer to Ranbaxy (May 16, 2007)
  • Granules sets timeline for enhanced capacity unit (May 15, 2007)
  • Dr Reddy's reviewing ruling (May 13, 2007)
  • Lambda Therapeutics buys Polish drug co (May 12, 2007)
  • Strides opens steriles unit in Brazil (May 12, 2007)
  • Strides buying Grandix for Rs 100 cr (May 10, 2007)
  • IFC picking up 11.48% stake in Granules India for $6 m (May 10, 2007)
  • Over-the-counter products to drive Elder Health sales (May 10, 2007)
  • AstraZeneca posts Indian officials abroad (May 10, 2007)
  • Matrix in pact with Clinton Foundation (May 10, 2007)
  • Merck's musical pursuits! (May 08, 2007)
  • Aurobindo Zolpidem gets FDA nod (May 08, 2007)
  • Avesthagen, AcuNova tie-up (May 05, 2007)
  • Nektar Therapeutics decides on India as second R&D hub (May 05, 2007)
  • Manipal AcuNova bags F&S award (May 03, 2007)
  • Govt in pact for developing AIDS vaccine (May 03, 2007)
  • Aurobindo drug gets S. African nod (May 02, 2007)
  • Rajinder Kumar joins Dr Reddy's (May 02, 2007)
  • Morepen Lab to raise authorised capital (May 02, 2007)
  • Dr Reddy's launches oncology drug (May 01, 2007)
  • ChrysCapital picks up Mankind stake (April 30, 2007)
  • 2 Lupin projects selected for funding (April 28, 2007)
  • Ranbaxy gets nod for Ambien (April 28, 2007)
  • Aurobindo Pharma gets S. African nod for Metformin (April 27, 2007)
  • Nicholas Piramal targets 25% growth this year (April 27, 2007)
  • Victoria invites investments in lifesciences (April 27, 2007)
  • Tie-up with Zuellig Pharma (April 27, 2007)
  • Shantha Bio offers five-in-one vaccine (April 26, 2007)
  • AIDS patients to protest in front of Abbott Labs (April 26, 2007)
  • USFDA nod for Dr Reddy's Zolpidem (April 26, 2007)
  • Decks cleared for Biocon's insulin plant (April 25, 2007)
  • USP lab gets ISO certification (April 25, 2007)
  • Jubilant acquires Hollister-Stier for $122.5 m (April 25, 2007)
  • Ranbaxy to invest $20 m in Terapia (April 21, 2007)
  • Reliance Retail plans health & wellness stores (April 21, 2007)
  • Promed Exports planning Rs 60-cr facility (April 21, 2007)
  • Wockhardt gets US nod for selling antibiotic injection (April 19, 2007)
  • Wockhardt plans silicone gel for treating scars (April 19, 2007)
  • Dr Reddy's to participate in pharmacopoeia verification (April 18, 2007)
  • Potkar is Pfizer Director (April 17, 2007)
  • Jupiter Bio board okays stake sale to Ranbaxy (April 14, 2007)
  • Alembic launching 7 new products (April 14, 2007)
  • Ranbaxy can sell Cefprozil in Canada (April 13, 2007)
  • Lupin plans increase in research spend (April 13, 2007)
  • Indian patent law — Needed, proper definition of `inventive step' (April 13, 2007)
  • `Unwise to challenge Patent Act' (April 12, 2007)
  • Hands-on training (April 09, 2007)
  • Jupiter Bio set for 10-year purchase pact with Ranbaxy (April 08, 2007)
  • Ranbaxy acquiring 14.9% stake in Jupiter Bio (April 07, 2007)
  • Roche bringing cancer drug to India (April 06, 2007)
  • Lupin receives patent payments (April 06, 2007)
  • Dr Reddys to publish audited results (April 06, 2007)
  • Aurobindo gets nod for Lisinopril (April 05, 2007)
  • United Biotech mulls Rs 15-cr oncology division (April 05, 2007)
  • Ranbaxy loses US apex court appeal in Lipitor case (April 04, 2007)
  • Granules India sells 13% stake to US co (April 04, 2007)
  • Ranbaxy, GSK to co-develop respiratory drug (April 03, 2007)
  • Glaxo set for cardiovascular drug launch soon (March 31, 2007)
  • Ranbaxy launches asthma inhalation capsules (March 30, 2007)
  • SMS Pharma's new tie up (March 30, 2007)
  • USV launches sweetener (March 30, 2007)
  • Ranbaxy okays 120% 2nd interim (March 30, 2007)
  • Aurobindo's joint venture gets USFDA nod for Cefriaxone (March 30, 2007)
  • USFDA nod for Strides' AIDS drug (March 29, 2007)
  • Wockhardt gets nod for diuretic sales in US (March 28, 2007)
  • Ammana Bio plans Rs 22-cr public issue (March 27, 2007)
  • Serum Institute launches HIB vaccine (March 27, 2007)
  • Glenmark acquiring Czech co Medicamenta (March 27, 2007)
  • AstraZeneca's new lab to host key research work (March 23, 2007)
  • Wockhardt gets nod for sale of painkiller in US (March 22, 2007)
  • iLabs to invest in MedPlus (March 22, 2007)
  • AstraZeneca global downsizing will not touch India, says CEO (March 22, 2007)
  • Jubilant bags $60m deals (March 21, 2007)
  • AstraZeneca winds up research society (March 21, 2007)
  • Divi's to pay 100% interim dividend (March 20, 2007)
  • Pfizer sells Chandigarh plant (March 17, 2007)
  • Ranbaxy gets USFDA nod to sell insomnia drug (March 17, 2007)
  • Zydus enters derma-care segment thru Liva buy (March 17, 2007)
  • Kerala Govt plans to float co to procure medicines (March 17, 2007)
  • Sun Pharma plans to spend Rs 300 cr in research (March 16, 2007)
  • Elder Pharma joins hands with Spanish co (March 15, 2007)
  • GSK to seek Drug Controller nod for breast cancer drug (March 15, 2007)
  • GVK Bio forms joint venture with INC Research (March 15, 2007)
  • Strides gets nod for 2 NDAs (March 15, 2007)
  • Ranbaxy faces legal action from Pfizer (March 14, 2007)
  • Himadri Sen is Ranbaxy's R&D chief (March 13, 2007)
  • Cadila Pharma to open plant in Ethiopia today (March 13, 2007)
  • Natco gesture to breast cancer patients (March 13, 2007)
  • Aurobindo gets FDA nod for drug (March 10, 2007)
  • Biocon unveils 5 renal therapy drugs (March 09, 2007)
  • For bird flu (March 09, 2007)
  • Terapia Ranbaxy gets Market Authorisations for 20 products (March 08, 2007)
  • Abbott India stock stays flat despite buyback offer (March 08, 2007)
  • `Novartis to continue with Glivec case' (March 07, 2007)
  • Granules India in outsourcing pact with Aussie co (March 06, 2007)
  • Glivec raises concerns on post-marketing study (March 06, 2007)
  • Strides AIDS drug gets USFDA nod (March 06, 2007)
  • Patent law should have guidelines to follow: Novartis (March 06, 2007)
  • US co to develop, sell Ranbaxy's statin (March 02, 2007)
  • Finnish nod for Aurobindo unit (March 02, 2007)
  • Polar Pharma enters US, Europe with new strategy (February 28, 2007)
  • Ethypharm, Shantha Biotech tie up (February 27, 2007)
  • Granules picks Ridgeback as strategic investor (February 27, 2007)
  • FMC opens organolithium plant near Hyderabad (February 27, 2007)
  • Drug `efficacy' may be open to interpretation (February 25, 2007)
  • Novartis case: Conversion of writ petitions referred to CJ (February 24, 2007)
  • Wockhardt targets $1-b revenue by 2009 (February 24, 2007)
  • Ranbaxy loses Flomax patent case (February 24, 2007)
  • Medicines as `merit' goods (February 24, 2007)
  • Aurobindo to sell ARVs in Botswana (February 23, 2007)
  • Ranbaxy Romania gets nod (February 23, 2007)
  • Novartis' charges against Indian patent law refuted (February 23, 2007)
  • Evolvence India to invest $10 m in Bangalore co (February 23, 2007)
  • Auto, pharma, IT sectors to propel India Inc: Study (February 22, 2007)
  • Lupin in IP deal for hypertension drug (February 21, 2007)
  • Aurobindo gets nod for Lisinopril (February 21, 2007)
  • Biocon to begin phase 2 nasal insulin trials (February 21, 2007)
  • Biocon to make insulin at new plant in Vizag (February 21, 2007)
  • Major fire at Cadila Pharma (February 20, 2007)
  • MHRA clears Strides plant (February 20, 2007)
  • Pharma-Bio award for IICT chief (February 19, 2007)
  • Dr Reddy's stock option allotment (February 18, 2007)
  • Biocon to invest Rs 500 cr in Pharma City (February 17, 2007)
  • Ranbaxy's US offices searched (February 16, 2007)
  • Nicholas Piramal to invest in UK (February 16, 2007)
  • Mankind Pharma lines up growth plans (February 15, 2007)
  • Zenotech scouts for overseas partners for biosimilar products (February 15, 2007)
  • Actavis acquires bulk drugs unit of Sanmar Speciality (February 14, 2007)
  • Ranbaxy launches generic Lipitor in Denmark (February 14, 2007)
  • Orchid Chem raises $200 m through FCCBs (February 14, 2007)
  • Ind-Swift undergoes FDA audit (February 11, 2007)
  • Krebs Bio to issue pref shares (February 10, 2007)
  • Ranbaxy to make, sell depression pills in US (February 10, 2007)
  • SMS Pharma IPO subscribed 2.6 times (February 09, 2007)
  • Pfizer may outsource application maintenance (February 09, 2007)
  • Genemedix to strengthen Reliance Life product pipeline (February 08, 2007)
  • Ranbaxy selects advisor for possible Merck deal (February 07, 2007)
  • Fortis to invest Rs 800 cr for foray into health stores (February 07, 2007)
  • Cadila to roll out `Sugar Free' boutiques (February 05, 2007)
  • Ranbaxy gets USFDA nod (February 04, 2007)
  • Aurigene in drug discovery tie-ups (February 04, 2007)
  • Orchid in marketing pact with Actavis (February 04, 2007)
  • SMS Pharma: Invest at cut-off (February 04, 2007)
  • Aurobindo drug gets approval (February 03, 2007)
  • Strides' new venture buys Oslo co (February 03, 2007)
  • Alembic acquires Dabur's domestic non-oncology biz (February 02, 2007)
  • FDA nod for Aurobindo drug (January 30, 2007)
  • Abbott India promoter exempted from making open offer (January 30, 2007)
  • SMS Pharma to raise Rs 98 cr via IPO (January 30, 2007)
  • Ranbaxy unveils 2 urology products (January 30, 2007)
  • Apollo Pharmacy launches ATM service (January 27, 2007)
  • Canadian court rules in Ranbaxy's favour (January 27, 2007)
  • To adopt Oracle tool (January 26, 2007)
  • Nicholas Piramal sets up inhalation anaesthetics plant in Hyderabad (January 25, 2007)
  • Bilcare signs pact with Honeywell (January 25, 2007)
  • Cabinet nod for 5 pharma institutes (January 25, 2007)
  • Orchid facility gets UK approval (January 24, 2007)
  • Wockhardt in pact with UK co (January 23, 2007)
  • Nicholas Piramal pact with Napo of US for diabetes drug (January 23, 2007)
  • Contract research revenues to touch $1 billion by 2010 (January 21, 2007)
  • Granules ties up with GSK Healthcare R&D (January 20, 2007)
  • Ess Dee posts Rs 9.16-cr net profit (January 19, 2007)
  • Biocon cancer drug to enter Pakistan (January 19, 2007)
  • USFDA approval for Aurobindo drug (January 19, 2007)
  • Bengal Chem revamp (January 17, 2007)
  • Pharma policy (January 15, 2007)
  • Nicholas Piramal to do clinical trials for Eli Lilly drugs (January 13, 2007)
  • Intas Biopharma ties up with US co (January 13, 2007)
  • `Ranbaxy will bid for Merck only at fair value' (January 11, 2007)
  • Suven Life gets EU patent for therapeutic agent (January 10, 2007)
  • Dabur buys Thai co's oncology sales biz (January 10, 2007)
  • Mylan buys 51.5 pc stake in Matrix (January 10, 2007)
  • Jupiter Bio bets big on peptide pharma (January 09, 2007)
  • Suven Life gets global certifications (January 09, 2007)
  • Alkem Labs forays into health foods segment (January 05, 2007)
  • Wellspring acquires Jankharia Imaging (January 05, 2007)
  • Aventis: Betting on earnings (January 04, 2007)
  • Lupin gets tentative USFDA nod (January 03, 2007)
  • Aurobindo gets 2 more approvals (January 03, 2007)
  • European acquisitions to boost Aurobindo's revenues (January 02, 2007)
    Corporate Results
  • Strides Q3 net down 97% on rupee rise (November 01, 2007)
  • Domestic sales drive Aurobindo Q2 net up 86% (November 01, 2007)
  • Suven Life net down 53% (October 31, 2007)
  • Divi Labs PAT up at Rs 91 cr (October 30, 2007)
  • Granules Q1 net at Rs 2.02 cr (October 30, 2007)
  • Cadila Healthcare net profit up (October 28, 2007)
  • GSK Pharma Q3 sales higher (October 27, 2007)
  • Sun Pharma confident of closing Taro deal (October 27, 2007)
  • Dabur Pharma net rises 23% but sales dip (October 27, 2007)
  • Vimta Labs Q2 net at Rs 1.6 cr (October 27, 2007)
  • Natco Q2 net rises 8% (October 26, 2007)
  • Strong rupee impacts Cipla’s performance (October 26, 2007)
  • Custom-manufacturing biz lifts Nicholas Piramal (October 26, 2007)
  • Earnings model keeps Lupin profits healthy (October 25, 2007)
  • Dr Reddy’s suffers on German arm’s showing (October 25, 2007)
  • HC to hear Glivec issue on Nov 6 (October 24, 2007)
  • Orchid Chem revenue up 20 % on drug filings (October 20, 2007)
  • Ranbaxy Q3 net profit up 48% on forex gains (October 19, 2007)
  • Strong rupee, staff costs drag Unichem net (October 19, 2007)
  • Shasun Chem posts 21% growth in revenues (October 18, 2007)
  • Jubilant Q2 profits double on higher sales (October 17, 2007)
  • Dishman Pharma net up 14% (August 02, 2007)
  • Torrent Pharma’s Q1 net increases 65% (August 02, 2007)
  • Granules India full year net up 14.6% (August 01, 2007)
  • Aurobindo Pharma PAT up 62% (August 01, 2007)
  • Suven Life PAT increases 51% (August 01, 2007)
  • Divi Labs PAT doubles to Rs 65 cr (August 01, 2007)
  • Glenmark Q1 consolidated net surges 206% (July 31, 2007)
  • Strides net doubles (July 30, 2007)
  • Vimta Labs net soars (July 29, 2007)
  • Matrix Lab net down 20% (July 29, 2007)
  • Natco Pharma PAT dips to Rs 7.7 cr (July 29, 2007)
  • GSK Pharma Q2 net up 6% (July 27, 2007)
  • Dabur Pharma Q1 net zooms (July 27, 2007)
  • Elder Pharma net rises (July 26, 2007)
  • Nicholas Piramal Q1 net slides 32% (July 26, 2007)
  • Unichem to set up SEZ in Madhya Pradesh (July 26, 2007)
  • Wockhardt consolidated net up 62% (July 26, 2007)
  • Panacea net dips 5% in Q1 (July 25, 2007)
  • Dr Reddy’s net up 31% at Rs 183 cr (July 24, 2007)
  • Cipla Q1 net profit down 30% (July 21, 2007)
  • Ranbaxy Q2 net profit zooms to Rs 266 cr (July 20, 2007)
  • Novartis net profit dips 11% at Rs 22.84 cr (July 20, 2007)
  • Jubilant Organosys Q1 net zooms to Rs 143 cr (July 19, 2007)
  • Aurobindo Q4 net up to Rs 78 cr (July 03, 2007)
  • Natco Pharma's revenue up (July 03, 2007)
  • Wanbury net jumps 4-fold (July 01, 2007)
  • Correction (June 26, 2007)
  • Zenotech Labs net up (June 22, 2007)
  • Panacea Biotec Q4 net doubles (June 15, 2007)
  • Matrix Labs net profit drops for full year, Q4 (May 25, 2007)
  • Divi's Labs Q4 net up 4 times; to split shares (May 24, 2007)
  • Alembic full-year net dips 10% (May 23, 2007)
  • Unichem Labs Q4 net rises on global biz growth (May 20, 2007)
  • Sun Pharma Q4 net rises 34% (May 19, 2007)
  • $1.5-b revenue lifts Dr Reddy's to the top slot (May 19, 2007)
  • Dabur Pharma Q4 net rises to Rs 2.72 cr (May 18, 2007)
  • Novartis Q4 net profit grows 19.4% (May 12, 2007)
  • Lupin Q4 net profit jumps on US sales (May 10, 2007)
  • Hikal net up in fourth quarter (April 29, 2007)
  • Jubilant Organosys fourth quarter net up at Rs 63.8 cr (April 29, 2007)
  • GlaxoSmithKline net profit rises (April 28, 2007)
  • Ranbaxy Q1 net profit rises 79% at Rs 128.7 cr (April 28, 2007)
  • Indoco Remedies net up 48% in Q3 (April 28, 2007)
  • Suven net up 24% in Q4 (April 27, 2007)
  • Zydus Cadila full year net jumps 53% (April 27, 2007)
  • Wockhardt clocks Rs 52-cr net in Q1 (April 27, 2007)
  • Cipla net down 34% (April 27, 2007)
  • Glenmark Q4 net doubles on US exports (April 26, 2007)
  • Mankind sales up 65% (April 25, 2007)
  • Biocon posts 27 pc rise in Q4 net profit (April 20, 2007)
  • Pfizer Q1 net profit up 14% (March 23, 2007)
  • Wockhardt Q4 net down 5.6% (February 23, 2007)
  • GlaxoSmithKline Pharma net up 60% (February 17, 2007)
  • Matrix posts loss; revenues at Rs 395.3 cr (February 02, 2007)
  • Suven Life net up; board okays 1:1 bonus, stock split (January 30, 2007)
  • Divi's Labs net climbs 66 pc at Rs 31 cr (January 28, 2007)
  • Vimta Labs net down (January 27, 2007)
  • Torrent Pharma Q3 net zooms (January 26, 2007)
  • Elder Pharma Q3 net profit up (January 24, 2007)
  • Glenmark Q3 net profit 63 pc higher at Rs 39 cr (January 24, 2007)
  • JB Chem Q3 sales rise (January 24, 2007)
  • Dabur Pharma profits up on global cancer drug sales (January 24, 2007)
  • Cipla Q3 net up at Rs 184 cr (January 24, 2007)
  • Cadila Q3 net rises 66 pc (January 23, 2007)
  • Generic sales inject more profits for Dr Reddy's (January 23, 2007)
  • Orchid Chem Q3 net flat (January 20, 2007)
  • Alembic Q3 net up 5 pc (January 19, 2007)
  • Nicholas Piramal Q3 net up 81 pc (January 19, 2007)
  • Ranbaxy's Q4 net more than doubles to Rs 186 cr (January 19, 2007)
  • Unichem Lab PAT up 5.62% (January 19, 2007)
  • Lupin net up 27% at Rs 56 cr (January 18, 2007)
    eWorld
  • Playing in the shallows (June 11, 2007)
    Home Page
  • Ranbaxy Labs: Buy (December 30, 2007)
  • Fake drugs across the price spectrum: WHO study (December 23, 2007)
  • Ipca Labs: Buy (December 16, 2007)
  • ‘Nanomedicine is at the frontline of new drug delivery’ (December 15, 2007)
  • Pfizer’s patent win may be positive for Indian arm (December 12, 2007)
  • It’s fake, it’s also grey and it’s Viagra (December 11, 2007)
  • Pharma vigilance panel to decide on controversial drugs (December 10, 2007)
  • Wockhardt to consolidate global operations; push to healthcare biz (December 08, 2007)
  • Novartis drops Exelon patent suit against Sun Pharma (December 06, 2007)
  • Sanofi-Aventis opens R&D centre in Goa (December 04, 2007)
  • Small-cap pharma stocks outshine Sensex (December 03, 2007)
  • GSK doubles clinical trials (November 26, 2007)
  • ‘Ranbaxy’s epilepsy drug recall may not attract lawsuits’ (November 24, 2007)
  • Strides deal: To result in cash infusion (November 21, 2007)
  • Nicholas in research deal with Merck (November 20, 2007)
  • 2-member Bench can look into Novartis’ Glivec case, says HC (November 14, 2007)
  • Combination drugs: Driven by science or commerce? (November 13, 2007)
  • Strong rupee, competition weaken pharma earnings (November 11, 2007)
  • ‘GSK’s strategy depends on market dynamics’ (November 10, 2007)
  • Glenmark reorganises biz into speciality and generic (November 08, 2007)
  • ‘Global pharma market expected to slow down in 2008’ (November 05, 2007)
  • India scores over China in US generic drug market (November 04, 2007)
  • Glenmark outlicences pain molecule to Eli Lilly; deal projected at $350 m (October 31, 2007)
  • Glenmark deal: Phase II success is crucial (October 31, 2007)
  • Dr Reddy’s new pill to revitalise betapharm (October 27, 2007)
  • Custom-manufacturing biz lifts Nicholas Piramal (October 26, 2007)
  • Pharmaceuticals: Demerger of R&D units — a new trend (October 22, 2007)
  • Are investors willing to bite the research bullet? (October 17, 2007)
  • Drug cos hiving off R&D units (October 15, 2007)
  • Pharma may trigger 3-fold rise in India-S. Africa trade: FICCI (October 14, 2007)
  • GIVE’s a generics booster for Indian drug makers (October 08, 2007)
  • Ranbaxy hikes stake in Zenotech Lab to 45% (October 04, 2007)
  • US ruling lands Indian drug makers in a soup (September 26, 2007)
  • Re impact: Pharma companies expanding currency baskets (September 25, 2007)
  • Pfizer gets relief on epilepsy drug as US court reverses ruling (September 25, 2007)
  • Ranbaxy drops patent challenge (September 23, 2007)
  • Safety concerns on GSK drug affect generic plans (September 22, 2007)
  • India’s opium report card ‘clean’ (September 19, 2007)
  • Opportunity knocks for Sun Pharma? (September 12, 2007)
  • 40 fixed-dose-combination drugs may be off chemists’ shelves (September 04, 2007)
  • Nicholas Piramal hiving off research unit (September 01, 2007)
  • Nicholas Piramal hiving off research unit (September 01, 2007)
  • ‘Novartis verdict has no bearing on the price of any drug’ (August 26, 2007)
  • Cipla’s drug gets on to US anti-AIDS initiative (August 17, 2007)
  • WHO registry to inject transparency into clinical trials (August 13, 2007)
  • HC stays IPAB proceedings on Novartis plea (August 10, 2007)
  • Novartis loses plea; HC upholds Patents Act provision (August 07, 2007)
  • ‘NPPA price fixing is indirect way of control’ (August 03, 2007)
  • IonIdea developing Conformia’s drug discovery software (July 25, 2007)
  • Drug companies will continue to face hard times (July 22, 2007)
  • Churn at State FDA, new chief appointed (July 19, 2007)
  • Central Drug Administration to become reality soon (June 22, 2007)
  • Safety not a concern yet for generics of Acomplia (June 20, 2007)
  • Virchow Labs hit by Chinese dumping duty (June 17, 2007)
  • Reliance Life Sciences looking out for acquisitions (June 14, 2007)
  • Strides Arcolab buys Grandix for Rs 100 cr (June 12, 2007)
  • Nicholas Piramal ties up for cancer, diabetes research (June 11, 2007)
  • GSK's diabetes drug may need addl warning (June 08, 2007)
  • Appellate board to hear Novartis case on June 18 (June 07, 2007)
  • After Baddi, AP bulk drug cos now eyeing Nanded, Raichur (June 05, 2007)
  • `Price may not be trump card for domestic drug cos for long' (June 04, 2007)
  • Mandatory training soon for medical shop personnel (May 26, 2007)
  • Alembic in licensing pact with Belgian co (May 24, 2007)
  • Reliance setting up pharma unit at Jamnagar SEZ (May 23, 2007)
  • Sun Pharma buys Israel co for $454 m (May 22, 2007)
  • Dabur Pharma eyes global buys (May 18, 2007)
  • DCGI plan to curb export of fake drugs (May 13, 2007)
  • Ranbaxy concludes Be-Tabs buyout in S. Africa (May 09, 2007)
  • Cipla receives 2nd notice for `overcharging' (May 06, 2007)
  • Strides, US co Accu-Break call off joint venture plan (May 03, 2007)
  • Abbott's anti-AIDS drug may become cheaper (May 01, 2007)
  • Drug-makers build business bridges in Japan (April 23, 2007)
  • Zydus Cadila acquires Japan's Nippon Universal (April 20, 2007)
  • Cipla readying response to Govt's notice (April 15, 2007)
  • GoM to discuss drug pricing issue this week (April 09, 2007)
  • Ranbaxy acquiring 14.9% stake in Jupiter Bio (April 07, 2007)
  • `Clearance for clinical trials quicker in India' (April 07, 2007)
  • Novartis cancer drug case shifts to new board (April 05, 2007)
  • Indian drugs find new markets (April 02, 2007)
  • Value buying helps pharma stocks (March 31, 2007)
  • Wockhardt opposes Roche patent on Pegasys (March 30, 2007)
  • Glenmark in patent challenge over cholesterol drug (March 29, 2007)
  • Bulk drugs prices in for marginal cut (March 20, 2007)
  • Biocon arm to set up research facility for Bristol Myers (March 15, 2007)
  • Ranbaxy bids for Merck's generic business (March 14, 2007)
  • Pharma sector in throes of top-level management churn (March 13, 2007)
  • Glenmark inks deal with Dyax for biologics (March 13, 2007)
  • `Novartis to continue with Glivec case' (March 07, 2007)
  • Drugs sector unhappy with lukewarm treatment (March 01, 2007)
  • Domestic pharma cos differ on Mashelkar report (February 21, 2007)
  • Local research on drugs may get tax sops in Budget (February 12, 2007)
  • Dabur Pharma, Hospira likely to part ways (February 08, 2007)
  • Pharma industry opposes price control mechanism (January 11, 2007)
  • Ranbaxy to bid for Merck's generic biz by Jan-end (January 10, 2007)
  • `New price control to affect only 12% of drugs market' (January 08, 2007)
  • Nanotech-based drug delivery system from Dabur (January 05, 2007)
  • Ranbaxy gets US FDA approval for hypertension drug (January 03, 2007)
    Industry & Economy
  • Pharma sector's mixed bag of fortunes (December 29, 2007)
  • Gujarat pharma industry centenary celebrations on Jan 5 (December 28, 2007)
  • CSIR chief for a public portal on drug research (December 24, 2007)
  • ‘50,000 clinical staff needed in next 2 years’ (December 18, 2007)
  • BSE-Healthcare outperforms other sectoral indices (December 15, 2007)
  • M&A the main driver for value unlocking in Indian pharma (December 06, 2007)
  • Combination drugs: Controller to file affidavit (December 06, 2007)
  • Kerala warns druggists (December 04, 2007)
  • Call for joint ventures with EU in pharma (November 30, 2007)
  • Pharmexil urges Centre to extend EoU sops (November 29, 2007)
  • NPPA issues notices for Rs 736 cr for overcharging (November 27, 2007)
  • Combination drugs: Driven by science or commerce? (November 13, 2007)
  • Strong rupee, competition weaken pharma earnings (November 11, 2007)
  • Combination drugs: Window open for fast-track approval (November 05, 2007)
  • ‘Global pharma market expected to slow down in 2008’ (November 05, 2007)
  • Pharma policy: GoM meet put off (November 03, 2007)
  • Patients’ patience (October 29, 2007)
  • GTZ signs pact to aid pharma SMEs (October 23, 2007)
  • Pharma body plea to cut interest on shipment credit (October 23, 2007)
  • No cure-all prescription (October 22, 2007)
  • NIPER premises inaugurated in Hyderabad (October 22, 2007)
  • Cheerful launch (October 20, 2007)
  • Medicine Shoppe looking beyond Mumbai (October 19, 2007)
  • Rupee appreciation takes toll on healthcare sector (October 10, 2007)
  • Price control eclipsing public health? (October 01, 2007)
  • Drug cos rethink strategies to offset rupee impact (September 26, 2007)
  • Jawahar Pharma City to begin operations soon (September 25, 2007)
  • DCA seizes spurious drugs worth Rs 5.36 cr (September 21, 2007)
  • Treatment of pharma R&D costs (September 20, 2007)
  • NPPA leans on IISc’s chemistry advice (September 19, 2007)
  • GoM hears industry views on pharma policy (September 13, 2007)
  • Novartis case: Govt seeks time to submit arguments (September 11, 2007)
  • Indian generic makers lead race for Coreg market (September 07, 2007)
  • Hyderabad pharma cluster to benefit from German Technical Corporation (August 24, 2007)
  • Patented drugs inflow set to grow, says McKinsey (August 24, 2007)
  • Patents: A questionable right (August 21, 2007)
  • Madras High Court: The Novartis judgment — Choosing innovation benefits India (August 21, 2007)
  • Bulk drug exporters set to hike prices (August 20, 2007)
  • Stiff penalties for fake drug makers (August 16, 2007)
  • Ramky group setting up pharma incubation centres (August 09, 2007)
  • ‘No scramble for stocking bird flu drug Oseltamivir’ (August 09, 2007)
  • Ranbaxy, GSK settle Valtrex patent row (July 27, 2007)
  • Pharma body may fix price for 10 additional drugs (July 17, 2007)
  • Fake drugs issue in focus after three-year gap (July 16, 2007)
  • A ‘360-degree’ look to stem biotech attrition (July 06, 2007)
  • Innovation or imitation — the Hobson's choice (June 26, 2007)
  • Drug clinical trials may be outsourced to India (June 26, 2007)
  • ICMR setting up SubbaRow centre (June 16, 2007)
  • NPPA fixes prices for eight non-scheduled drugs (June 15, 2007)
  • Talent retention tops HR priorities in pharma industry (June 15, 2007)
  • Drug pricing body regains powers (June 14, 2007)
  • Advinus collaborates with local cos for research (June 08, 2007)
  • Panel report on data exclusivity for drugs today (May 31, 2007)
  • Ranbaxy allowed to launch generic Lipitor (May 30, 2007)
  • TCG Life offers R&D for entire drug development lifecycle (May 24, 2007)
  • `India key geography in Asian pharma growth story' (May 22, 2007)
  • Pharma cos facing stiff pricing pressure in US (May 20, 2007)
  • DRUG PRICE COMPENDIUM (May 16, 2007)
  • Lupin, Glaxo part ways on Philippines agreement (May 15, 2007)
  • QuantumID plans RFID solution for pharma sector (May 03, 2007)
  • Pharmexcil setting up IPR centre for small scale sector (May 03, 2007)
  • Niper secures 100 acres from IDPL, to invest Rs 180 cr (April 30, 2007)
  • Big players eyeing pharma SMEs (April 28, 2007)
  • Pharma sector can make waves, says Anji Reddy (April 25, 2007)
  • PIL on spurious drugs: `Implement Mashelkar panel recommendations' (April 20, 2007)
  • Eco norms begin to bite small, medium units in pharma space (April 18, 2007)
  • Patent regime triggers thrust on healthcare communication (April 06, 2007)
  • Ekta Incubation Centre gets lab for pathogen research (April 02, 2007)
  • Transparency sought in drug trials on animals (March 27, 2007)
  • `Jawahar Pharma City attracting major cos' (March 17, 2007)
  • Price rise limit for non-scheduled drugs (March 17, 2007)
  • Medicine labels to be simplified (March 08, 2007)
  • Cautious cheer to Centre's efforts on AIDS (March 02, 2007)
  • Cos conducting clinical trials can now compete on prices (March 02, 2007)
  • Sports Broadcasting, NIPER Bills introduced in LS (March 02, 2007)
  • A non-event: Satish Reddy (March 01, 2007)
  • Sweet pill for pharma (March 01, 2007)
  • Pharma sector turnover to double by 2010 (February 28, 2007)
  • `Peptide-based drug development offers growth' (February 23, 2007)
  • Bengal plans to set up drugs, medical equipment unit (February 22, 2007)
  • Need long-term research incentives for pharma sector (February 18, 2007)
  • VUDA moves against Pharma City (February 12, 2007)
  • Drugs patented abroad: Panel to evolve negotiated pricing formula (February 10, 2007)
  • GlaxoSmithKline, Ranbaxy to expand R&D alliance (February 07, 2007)
  • CPI (M) urges Govt to fight Novartis patent challenge (February 04, 2007)
  • Redefine `essential drugs' list: Pharma industry (February 03, 2007)
  • `Streamline customs norms to boost pharma exports to China' (January 30, 2007)
  • Drug IPR: Where India must not `trip' (January 24, 2007)
  • GoM to study draft pharma policy (January 12, 2007)
  • Pharma sector mulls alternative tax incentive package (January 09, 2007)
  • Drug retailers plan to network to stay competitive (January 05, 2007)
  • TN pharmacists urged to join VAT regime (January 05, 2007)
    Investment World
  • Take Solutions — IPO: Invest at cut-off (August 05, 2007)
  • Pharma: Glowing with growth (June 17, 2007)
    Opinion
  • Pharma research: The long and slippery road (December 05, 2007)
  • Irrational drugs — Living with the menace (November 28, 2007)
  • Networking technologies — Driving pharma industry growth (September 26, 2007)
  • Indian pharma industry — Coming out of the shadows (September 04, 2007)
  • Madras High Court: The Novartis Judgment
    A review of the after-effects
    (August 22, 2007)
  • Patents vs prices: Sugar coating a bitter pill (August 14, 2007)
  • `Clinical studies are subject to very strict rules and guidelines' (June 08, 2007)
  • Pharma sector — The non-linear innovation (March 27, 2007)
    Web Extras
  • Ocimum Bio gets $17 m from Kubera Cross Border Fund (December 18, 2007)
  • Taro to vote on Sun Pharma merger soon (December 07, 2007)
  • US co Generex in pact with Shreya Life for insulin spray (November 02, 2007)
  • Advinus plans inorganic growth, alliances (October 25, 2007)
  • Kemwell seeks funds for biologics unit in Bangalore (September 10, 2007)
  • ‘Demerger will put drug research on fast track’ (September 01, 2007)
  • ‘Demerger will put drug research on fast track’ (September 01, 2007)
  • Nicholas Piramal gets US nod for cancer compound (July 28, 2007)
  • US co Aptuit invests $100 m in Laurus Labs, forms new entity (June 20, 2007)
  • Gilead Sciences counts on Indian pharma companies (May 14, 2007)
  • Synchron acquires Innovance (April 05, 2007)
  • Mankind Pharma mulls new wing (March 30, 2007)
  • Jubilant signs $60-m global contracts (March 22, 2007)
  • Ranbaxy jumps on reports of not buying Merck business (March 21, 2007)
  • Aurobindo Pharma on course to emerge global generic major (March 10, 2007)
  • Seoul institute tech for Shantha Bio to make oral cholera vaccine (February 19, 2007)
  • Bharat Bio to do clinical trials for JE vaccine (February 14, 2007)
  • Zenotech ties up with Ranbaxy for EU market (February 08, 2007)
  • Marck Biosciences to expand capacity (January 25, 2007)
  • JB Chem to set up SEZ in Gujarat (January 18, 2007)
  • Claris launches anti-infective injection (January 05, 2007)


    Year : 2010 | 2009 | 2008 | 2006 | 2005 | 2004 | 2003 | 2002




  • The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
    Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

    Copyright © 2007, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line